Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q2 FY20 results · Jul–Sep 2019
Neuland Laboratories reported revenue from operations of ₹186.22 crore and net profit of ₹8.69 crore for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 186.22 | — | — | 181.01 | +2.9% |
| Other income | 0.57 | — | — | 0.52 | +10.0% |
| Total income | 186.79 | — | — | 181.53 | +2.9% |
| Profit before tax | 12.45 | — | — | 7.60 | +63.9% |
| Net profit for the period | 8.69 | — | — | 5.71 | +52.2% |
| EPS, basic (₹) | 6.77 | — | — | 4.45 | +52.1% |
| Net margin (%) | 4.7 | — | 3.2 |
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 186.21 | 168.74 | +10.4% | 181.01 | +2.9% |
| Other income | 0.57 | 0.64 | −10.8% | 0.52 | +10.0% |
| Total income | 186.78 | 169.38 | +10.3% | 181.53 | +2.9% |
| Profit before tax | 12.33 | 5.30 | +132.7% | 7.51 | +64.3% |
| Net profit for the period | 8.57 | 4.40 | +94.6% | 5.61 | +52.6% |
| EPS, basic (₹) | 6.68 | 3.43 | +94.8% | 4.38 | +52.5% |
| Net margin (%) | 4.6 | 2.6 | 3.1 |
Consolidated
- Filed with BSE
- 19 Nov 2019, 12:47 IST
- Board meeting
- 14 Nov 2020
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 19 Nov 2019, 12:47 IST
- Board meeting
- 14 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE